Abbvie Inc. Bayer Aktiengesellschaft
Biogen Inc. Bristol-Myers Squibb Company
F. Hoffmann-La Roche AG (Roche Holding AG)
GlaxoSmithKline Plc
Merck & Co. Inc. Novartis AG
Sanofi S.A. and Teva Pharmaceutical Industries Ltd.
Published | Pages | Publisher | Report code |
---|---|---|---|
Nov 2023 | 144 | iMarc Group | ASDR-639873 |
Abbvie Inc. Bayer Aktiengesellschaft
Biogen Inc. Bristol-Myers Squibb Company
F. Hoffmann-La Roche AG (Roche Holding AG)
GlaxoSmithKline Plc
Merck & Co. Inc. Novartis AG
Sanofi S.A. and Teva Pharmaceutical Industries Ltd.